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Immunocytochemical detectionof dentin matrix proteins in primary teeth from patientswith dentinogenesis imperfectaassociated with osteogenesisimperfecta
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Abstract
Dentinogenesis imperfecta determines
structural alterations of the collagen structure
still not completely elucidated. Immunohisto -
chemical analysis was used to assay type I and
VI collagen, various non-collagenous proteins
distribution in human primary teeth from
healthy patients or from patients affected by
type I dentinogenesis imperfecta (DGI-I) asso-
ciated with osteogenesis imperfecta (OI). In
sound primary teeth, an organized well-known
ordered pattern of the type I collagen fibrils
was found, whereas atypical and disorganized
fibrillar structures were observed in dentin of
DGI-I affected patients. Expression of type I
collagen was observed in both normal and
affected primary teeth, although normal dentin
stained more uniformly than DGI-I affected
dentin. Reactivity of type VI collagen was sig-
nificantly lower in normal teeth than in dentin
from DGI-I affected patients (P<0.05).
Expressions of dentin matrix protein-1
(DMP1) and osteopontin (OPN) were observed
in both normal dentin and dentin from DGI-I
affected patients, without significant differ-
ences, being DMP1 generally more abundantly
expressed. Immuno labeling for chondroitin
sulfate (CS) and biglycan (BGN) was weaker
in dentin from DGI-I-affected patients com-
pared to normal dentin, this decrease being
significant only for CS. This study shows ultra-
structural alterations in dentin obtained from
patients affected by DGI-I, supported by
immunocytochemical assays of different col-
lagenous and non-collagenous proteins.
Introduction
Type I collagen is the major extracellular
matrix protein in dentin comprising 85-90% of
the organic matrix. Type I collagen is a triple
helix containing two alpha 1 and one alpha 2
polypeptides, which are expressed from
COL1A1 and COL1A2. Mutations in these
genes cause osteogenesis imperfecta (OI), an
autosomal dominant form of brittle bone dis-
ease.1 OI is usually classified on the basis of
clinical and radiologic criteria in 4 types.1 Each
of the 4 types of OI is further subdivided on the
presence or absence of the developmental den-
tal defect known as dentinogenesis imperfecta
(DGI), in which three types can be recognized:
DGI-I, DGI-II, and DGI-III.1-3
DGI-I is the dental phenotype recorded in
patients affected by OI, which has been noted
to be OI types III and IV in approximately 80%.1
Clinically, teeth show marked discoloration,
tendency of normal enamel to crack off, bul-
bous crowns, short roots and attrition in both
the deciduous and permanent dentitions.3
Pulpal obliteration occurs soon after eruption
or prior to tooth eruption,3 varying, even within
a single individual, from total pulpal oblitera-
tion to normal pulp dimensions.1 Although pre-
vious studies largely discussed on the genetic
changes occurring in OI, little is known on
phenotype changes of dentin structure and
ultrastructure in patients also showing DGI-
I.4,6 Dentin of DGI-I affected patients has been
reported to show irregular texture of dentinal
areas, abnormal number and structure of
dentin tubules, areas of atubular dentin,5 and
ultrastructural abnormalities in the appear-
ance and organization pattern of collagen
fibers.4 Immuno-electron microscopy studies
have assayed reactivity for different types of
collagen, showing presence of type VI collagen
and decreasing of type I collagen expression in
DGI-I affected dentin.2,6 Moreover, DGI-I affect-
ed patients displayed reactive zones for the
non-collagenous protein fibronectin, alternat-
ing layerwise or concentrically with non-reac-
tive ones.2
Non-collagenous proteins (NCPs) have been
shown to play fundamental roles in actively
promoting, controlling, and regulating fibrillo-
genesis, crystal growth, and mineralization
during dentinogenesis.7 However, no recent
immunocytochemical studies have defined
whether there is a correlation among the dif-
ferent alterations described in collagenous and
non-collagenous dentin components in DGI-I
affected patients. Among the NCPs, special
interests have been given to some small
leucine-rich proteoglycans (including chon-
droitin 4/6 sulphate (CS)-rich decorin and
biglycan), and to certain glycoproteins (includ-
ing the prominent members of the SIBLINGs
family: dentin matrix protein-1 and osteopon-
tin), during predentin fibrillogenesis and
dentin mineralization, respectively.8,9
Therefore, the aim of the present study was
to elucidate morphological alterations of defec-
tive dentin in patients affected by DGI-I and OI,
by ultrastructural and immunocytochemical
analyses. Type I and VI collagen, dentin matrix
protein-1 (DMP-1), osteopontin (OPN), bigly-
can (BGN), and chondroitin sulfate (CS) were
investigated. The tested hypothesis was that
no correlation exists between the ultrastruc-
tural abnormalities of dentin affected by type I
DGI (associated with OI) and defective produc-
tion of both collagenous and NCPs.
Materials and Methods
All reagents were purchased from Sigma
Aldrich (St. Louis, MO, USA), unless otherwise
specified.
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Ten primary teeth exfoliated from five
patients affected by DGI associated with OI
were used in this study. Five human primary
teeth exfoliated were used as controls. The
subjects had a mean age of 6.1 years. The con-
sent form and experimental protocol was
approved by the Ethics Committee of the "AO
Spedali Civili" of Brescia (Italy). Following
extraction, teeth were cut with a low speed dia-
mond saw and sectioned to obtain 1 mm-thick
dentin disks. The disks were immediately fixed
in 4% paraformaldehyde and 0.1% glutaralde-
hyde buffered with 0.1 M sodium cacodylate, at
pH 7.2 overnight at 4°C.Immunocytochemical procedure
After fixation, disks were rinsed for 1 h in
0.1 M cacodylate buffer pH 7.4, and decalcified
using 4.13% EDTA for three months at 4°C.
Specimens were then extensively rinsed with
0.1M sodium cacodylate buffer, dehydrated in
graded concentrations (50, 70, 90, 95 and
100%) of ethanol and embedded in LR White
resin (London Resin, Berkshire, UK). Semi-
thin sections (1 m) were cut with glass
knives on a Reichert Jung Ultracut E ultrami-
crotome and stained with toluidine blue.
Selected areas of the specimens were trimmed
for ultra thin sectioning (80 nm) using a dia-
mond knife. Sections were mounted on
Formvar carbon-coated nickel grids.
Grid-mounted tissue sections were
processed for immunocytochemical labeling
using the following primary antibodies: rabbit
anti-type VI collagen (Fitzgerald Ind. Int.,
Acton, MA, USA) and mouse anti-type I colla-
gen (C2456, Sigma Aldrich), rabbit anti-DMP-
1 (LF-160, generously donated by Dr. Larry
Fisher, National Institute of Dental and
Craniofacial Research, Bethesda, MD, USA),
rabbit anti-OPN (LF-166, generously donated
by Dr. Larry Fisher), mouse anti-CS (CS-56,
Sigma Aldrich), rabbit anti-BGN (LF-51, gener-
ously donated by Dr. Larry Fisher) as previous-
ly reported.8,9 In brief, sections were immersed
in 0.05 M Tris HCl buffered solutions (TBS) at
pH 7.6, pre-incubated with normal goat serum
for 30 min, and incubated overnight with each
on of the above mentioned primary antibodies
at 4°C. Gold labeling was performed using
anti-mouse IgG secondary antibodies conjugat-
ed with 15-nm nanoparticles and goat anti-rab-
bit IgG secondary antibodies conjugated to 15
nm gold nanoparticles (British BioCell
International, Cardiff, UK) diluted 1:100 in
0.02 M Tris HCl buffered solutions (TBS) at pH
8.2. After labeling, grids were rinsed and
stained with 4% uranyl acetate and lead citrate
for examination with a Zeiss EM 109 electron
microscope. 
Controls consisted of sections incubated a
with a secondary antibody only; and substitut-
ing the primary antisera with non-immune
serum. For each antigen, gold particle density
was calculated in 20 different areas correspon-
ding to 20,000X magnification (area of 3898
µm2) using the Philips CM10 microscope and
Megaview software system (FEI Company,
Eindhoven, The  Netherlands). Statistical dif-
ferences were assessed by Student t-test
(P<0.05) and it was performed with GraphPad
Prism 5.0 software (San Diego, CA, USA).
Results
Structural and ultrastructural features and
expression patterns of various collagenous and
non-collagenous proteins in sound primary
teeth and teeth from patients affected by DGI-
I, associated with OI were assayed. Light
microscopy showed paucity and irregularity of
tubules in the dentin of DGI-I affected patients
(Figure 1 a,b). 
Ultrastructural examination showed the
dentin of DGI-I affected patients with thick,
sparse and a few lax curvy bundles of cross-
striated collagen fibers, whereas uniform
dense collagen pattern was recognizable in
sound primary dentin (Figure 1 c,d). Table 1
summarizes the quantification of the labeling
for the collagenous and non-collagenous
examined proteins. BGN, and CS showed a
weaker reactivity in dentin from DGI-I affected
patients compared to controls, being signifi-
cant only for CS (Figure 2 a,b; Figure 3). Type
I collagen was expressed both in sound and
DGI-I affected dentin without showing signifi-
cant differences. Conversely, type VI collagen
labeling was significantly more detected in
specimens from DGI-affected patients than in
controls (Figure 2 c,d). 
Regarding DMP1 and OPN expression,
dentin from DGI-I affected patients showed
pattern of loose collagen fibrils, labeled for
both DMP1 and OPN, whereas control speci-
mens exhibited a more uniform staining,
although there was no differences in the
count of gold particles for both DMP1 and
OPN, being DMP1 generally more abundantly
expressed in both sound primary teeth and
DGI-I affected ones (Figure 3 a-d). CS was
detected in normal dentin, mainly localized
inside the dentin tubules (Figure 3e), where-
as it was slightly detected in the DGI-I affect-
ed specimens (Figure 3f), as well as BGN,
which was present in controls (Figure 3g)
and less present in dentin specimens from
DGI-I affected patients (Figure 3h). In all neg-
ative controls either no labeling or a very few
gold particles were observed over the tissue
sections (Figure 4).
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Figure 1. Light micrographs showing dentin of a) exfoliated sound primary teeth, pre-
senting an uniform tubular structure and b) type I dentinogenesis imperfecta (DGI-I)
affected teeth, presenting paucity and irregularity of tubules, toluidine blue staining. c,d)
Transmission electron micrographs showing: c) normal dentin with uniform dense colla-
gen pattern and tubular structure; d) DGI-I affected dentin characterized by a collagen
fibrillar immature pattern not well arranged in lax curvy bundles. 
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Discussion
The tested hypothesis that there is no corre-
lation between the ultrastructural findings in
dentin from DGI-I affected patients and defec-
tive expression patterns of collagenous and
NCPs is partially rejected, since ultrastructural
abnormalities of the dentin matrix from DGI-I
affected patients corresponded to a different
expression of some of the examined proteins:
in particular CS was less expressed and type VI
collagen was more expressed in specimens
from DGI-I affected patients than in sound pri-
mary teeth, respectively. No significant differ-
ence was detected in the labeling of type I col-
lagen and the NCPs DMP 1, OPN and BGN
between normal and DGI-I affected dentin. Our
analysis focused on the primary teeth exfoliat-
ed by DGI-I affected patients since the primary
dentition is usually more affected by DGI than
the permanent teeth.1 Interestingly, primary
dentin obtained by DGI-I affected patients was
poor of dentinal tubules and showed dysplastic
dentin, characterized by sparse and coarse col-
lagen fibrils, which resemble more the pre-
dentin than the dentin typical features.10
As a dentin precursor, predentin is mineral-
ized when apatite crystals are deposited within
and around collagen fibrils.11 This process
requires mechanisms that control the site and
rate of apatite formation. Although the mecha-
nisms that control mineralization are largely
unknown, NCPs in dentin have been proposed
to be critical for this process during dentino-
genesis.7,11-13 We may speculate that the abnor-
mal distribution of NCPs within the dentin
matrix we assayed in DGI-I affected patients
may also affect the mineralization process,
leading to the suboptimally mineralized areas
that characterize DGI-I.14 This lack of mineral-
ization has been previously characterized as
bone fragility for patients affected by osteoge-
nesis imperfecta and was also extensively
reported as defective dentin calcification in
teeth affected by DGI-I,15-18 that wear more eas-
ily and excessively compared to normal
teeth.14,19,20
It is well known that identifying and
immunolabeling type I collagen fibrils within
mineralized tissues is challenging due to the
low accessibility and low antigenicity. The
labeling protocol employed in this study can be
considered highly selective in identifying alter-
ations in the protein epitopes as antigenicity
of collagen revealed by its specific binding to a
monoclonal antibody provides evidence of con-
servation of the epitope structure.4,21 Epitopes
for type I collagen antibodies can be divided in
relation to their ability to interact with the col-
lagen structure in helical, central and termi-
nal. Anti-helical type I collagen antibody (such
as the one used in this study) recognizes the
epitope based on three-dimensional structure,
that is strictly related to the intact triple helix.
Indeed this type of antibody binds only the
native form of collagen type I, while no labeling
occurs with denatured collagen molecules.
In previous studies on sound and carious
human dentin, anti-type I collagen monoclonal
antibody was used to assay the preservation of
the collagen structure.9,22-24 Interestingly, in the
present study specimens harvested from DGI-I
affected patients do not showed a reduced
labeling for type I collagen compared to sound
teeth. This labeling of the monoclonal anti-
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Figure 2. Transmission electron micrographs showing immunolabeling for type I colla-
gen (Coll-I) in dentin of: a) sound exfoliated primary teeth; b) type I dentinogenesis
imperfecta (DGI-I) affected teeth; c) immunolabeling for type VI collagen in sound
dentin used as control; d) DGI-I affected dentin. 
Table 1. Comparison of the number of gold particle-antibody complexes/ m2 after labeling for collagenous and non-collagenous proteins
in dentin areas of sound primary teeth and teeth affected by type I dentinogenesis imperfecta.
                                                         Sound primary teeth                     DGI-I affected teeth                                          P value
                                                                    (n=20)                                            (n=20)                                                           
Collagenous proteins                                                                                                                                                                                                                       
        Type I collagen                                                    8.53±2.47                                                      10.44±4.92                                                                       0.13
        Type VI collagen                                                  4.68±0.15                                                      11.83±3.56                                                                   <0.001*
Non collagenous proteins                                                                                                                                                                                                              
        Chondroitin sulphate                                        8.98±1.81                                                       1.58±0.61                                                                    <0.001*
        Dentin matrix protein 1                                   21.93±5.65                                                     20.32±6.17                                                                       0.22
        Osteopontin                                                        6.48±1.77                                                       7.73±2.59                                                                       0.083
        Biglycan                                                                6.34±0.94                                                       2.30±0.31                                                                       0.071
DGI-I, type I dentinogenesis imperfecta. All values are expressed as means and standard deviations (SD). *Statistical difference at P<0.05.
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type I collagen (clone COL 1) seems not to be
affected by the well-known mutations observed
in DGI-I, involving either of the two genes
encoding type I collagen.25
Whereas weak in normal teeth, staining for
type VI collagen was moderately present in
dentin from DGI-affected patients. These find-
ings confirm a previous study in which posi-
tive reactivity for collagen VI in the dentin of
primary teeth affected by both type I DGI (asso-
ciated with OI) and type II DGI.6 Labeling of
type VI collagen in our specimens was similar
to the one observed by Waltimo et al., which
reported that the gold particles were often sin-
gle, attached to non-striated material with a
low electron density and also seen intratubu-
larly.6 Interestingly, the reported lack of miner-
alization of the dentin matrix obtained by
patients affected by DGI-I14,19,20 is not clearly
supported by the labeling detected for the
major NCPs proteins implicated in the miner-
alization process such as DMP-1 and OPN
(that were not significantly different between
sound and affected primary teeth), whereas
there were significant decrease only of CS
expression in the DGI-I affected specimens
compared to the normal dentin. Therefore, the
main evidences are based on morphological
changes and specific features that DGI-I affect-
ed specimens present: collagen fibrils in sound
dentin showed opaque cross-striations, while
collagen fibrils in DGI-dentin showed clear
cross-striations. Noteworthy is that the pres-
ent report for the first time quantify the pres-
ence of some of the collagenous and NCPs
present indentin. Indeed, there are no reports
examining the role of NCPs in type I DGI,
whereas, for instance, dentin sialophosphopro-
tein (DSPP) has been previously investigat-
ed.26 A correlation between the defective cleav-
age of DSPP into DPP, in types II and III DGI,
has been assayed whereas no clear correlation
have been found between type I DGI and other
enzymes cleaving the major NCPs proteins of
dentin ECM.26 A recent paper has pointed out
that many similarities exist between gene and
protein structures of DSPP and DMP-1.27 Both
DSPP and DMP-1 contribute to hard tissue
mineralization and DMP1 plays a regulatory
role in dentin mineralization and can also
function as a signaling molecule.28 In fact, a
study characterizing DMP-1 null mice, clearly
demonstrated that DMP-1 is required for
dentin mineralization and that DSPP can be
directly or indirectly controlled by DMP-1.12,29
Moreover, Chaussain et al., investigated the
potential cleavage of DMP-1 by MMP-2 to
release biologically active peptides.30 MMP-2 is
a predominant protease in the dentin matrix
that plays a prominent role in tooth formation
and extracellular matrix degradation.31 DMP1,
both in the recombinant form and in its native
state within the dentin matrix, was shown to
be a substrate for MMP-2.30 Similarly, DMP-1
has been showed to be a possible substrate
also for MMP-9.32 Future studies may focus on
the expression of MMP-2 nor MMP-9 to clarify
their role in the DGI-I disease and to further
analyze the expression of the major NCPs and
correlated MMPs in carious tissues of DGI-I
affected teeth.33,34
Small leucine-rich PGs, including chon-
droitin 4/6 sulphate (CS)-rich decorin and
BGN, have some important functional implica-
tions in collagen assembly of predentin.9 In
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Figure 3. Transmission electron micrographs showing immunolabelig for: a) Dentin
matrix protein 1 (DMP-1) in dentin of sound primary teeth used as controls; b) DMP-1
in dentin of type I dentinogenesis imperfecta (DGI-I) affected teeth; c) osteopontin
(OPN) in sound dentin; d) OPN in DGI-I affected dentin; e) chondroitin sulphate (CS)
in sound dentin; f ) CS in DGI-I affected dentin; g) biglycan (BGN) in sound dentin; h)
BGN in DGI-I affected dentin. 
No
n c
om
me
rci
al 
us
e o
nly
[European Journal of Histochemistry 2014; 58:2405] [page 305]
particular, the suggested role of BGN is to reg-
ulate the growth and proliferation of mineral
crystals and has been usually found more
abundantly in predentin than in mineralized
dentin, in which was generally localized in the
mineralization front and within the dentinal
tubules.8 The weak labeling revealed in DGI-I
affected specimens for both CS and BGN
(which was significantly weaker only for CS)
may suggest that the defective unmineralized
dentin does not present the same features of
normal predentin, in which increasing of BGN
was expected. These data are in partial agree-
ment with the study by Ye et al., in which DMP-
1 null mice, characterized by dentin hypomin-
eralization and expanded pulp cavities,
showed no increasing of BGN production.12
In conclusion, although regulatory mecha-
nisms for the expression of NCPs have not been
fully elucidated, the present study correlates
morphological alteration of dentin from patients
affected by type I DGI with immunocytochemical
findings, helping to elucidate the ultrastructural
changes observed in dentin defects (currently
classified as distinct entities). This may be a con-
tribution to understand the pathogenesis of differ-
ent types of heritable dentin defects as well as aid
in early diagnosis of these diseases. Further stud-
ies related to the complicated interactions
between the extracellular matrix macromolecules
of dentin obtained by DGI-I affected patients are
needed to fully clarify biochemical alterations that
lead to deficient dentin formation.
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